BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33880366)

  • 21. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
    Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
    Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening candidate microRNA-mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis.
    Dai P; He Y; Luo G; Deng J; Jiang N; Fang T; Li Y; Cheng Y
    J Cell Biochem; 2019 Oct; 120(10):16798-16810. PubMed ID: 31090103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
    Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
    J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of lncRNA-miRNA-mRNA regulatory network associated with epithelial ovarian cancer cisplatin-resistant.
    Zhao X; Tang DY; Zuo X; Zhang TD; Wang C
    J Cell Physiol; 2019 Nov; 234(11):19886-19894. PubMed ID: 30950060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
    Zeng JH; Xiong DD; Pang YY; Zhang Y; Tang RX; Luo DZ; Chen G
    Oncotarget; 2017 May; 8(22):35681-35699. PubMed ID: 28415685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of competitive endogenous RNAs network in breast cancer.
    Wang X; Wan J; Xu Z; Jiang S; Ji L; Liu Y; Zhai S; Cui R
    Cancer Med; 2019 May; 8(5):2392-2403. PubMed ID: 30932362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of miRNA-mRNA regulatory network revealed key genes induced by aflatoxin B1 exposure in primary human hepatocytes.
    Zhang Z; Tang D; Wang B; Wang Z; Liu M
    Mol Genet Genomic Med; 2019 Nov; 7(11):e971. PubMed ID: 31502424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying
    Liu XT; Liu TT; Wu MY; Chen QX; Zhuang JX; Wang Q
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):68-78. PubMed ID: 33470885
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
    Zheng L; Dou X; Ma X; Qu W; Tang X
    Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics analysis of differentially expressed miRNA-related mRNAs and their prognostic value in breast carcinoma.
    Zhang GM; Goyal H; Song LL
    Oncol Rep; 2018 Jun; 39(6):2865-2872. PubMed ID: 29693181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.
    Caporali S; Amaro A; Levati L; Alvino E; Lacal PM; Mastroeni S; Ruffini F; Bonmassar L; Antonini Cappellini GC; Felli N; Carè A; Pfeffer U; D'Atri S
    J Exp Clin Cancer Res; 2019 Jun; 38(1):272. PubMed ID: 31227006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of chemoresistance-associated microRNAs and hub genes in breast cancer using bioinformatics analysis.
    Wu M; Zhao Y; Peng N; Tao Z; Chen B
    Invest New Drugs; 2021 Jun; 39(3):705-712. PubMed ID: 33394259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
    Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
    Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated analysis of dysregulated long non-coding RNAs/microRNAs/mRNAs in metastasis of lung adenocarcinoma.
    Li L; Peng M; Xue W; Fan Z; Wang T; Lian J; Zhai Y; Lian W; Qin D; Zhao J
    J Transl Med; 2018 Dec; 16(1):372. PubMed ID: 30587197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Related Network and Differential Expression Analyses Identify Nuclear Genes and Pathways in the Hippocampus of Alzheimer Disease.
    Quan X; Liang H; Chen Y; Qin Q; Wei Y; Liang Z
    Med Sci Monit; 2020 Jan; 26():e919311. PubMed ID: 31989994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.